 Abbott | Abbott Laboratories, public healthcare company (NYSE ABT). Its Neuromodulation business includes Infinity and Liberta RC DBS and NeuroSphere programming. Robert B. Ford is parent chairman/CEO; this business is not an independent BCI startup. | Abbott Park, Illinois, United States |
 ABILITY Neurotech | ABILITY Neurotech SA, Wyss Center spin-off developing investigational ABILITY/ABALON neural interfaces. CEO/co-founder Rotem Kopel. Company reported $7M secured at spinout; $40M fundraising target and $50M prior programme R&D are not closed company equity rounds. | Geneva, Switzerland |
 Altoida | Precision-neurology company developing an AI-powered Digital NeuroMarker platform that analyzes augmented-reality tasks, motion, speech, and touch signals for cognitive assessment and CNS trials. | Washington, District of Columbia |
 ANT Neuro | Neurotechnology business/group encompassing ANT Neuro bv and ANT Neuro GmbH within neuromotion, with related developer eemagine. Supplies EEG and neuroscience systems. Martijn Schreuder leads the operating companies; reported revenue is not funding. | Berlin, Germany · Hengelo, Netherlands |
 Anthropic | Anthropic builds Claude, a family of frontier AI models used by consumers, developers, and enterprises, and does the underlying research on making highly capable systems interpretable, reliable, and steerable. | San Francisco, California · 🇺🇸 · USA |
 Arctop | Arctop builds hardware-agnostic brain-computer interface software that decodes consumer EEG from headphones, earbuds, and glasses into real-time metrics such as attention, cognitive load, and enjoyment. The company licenses an SDK and API layer to developers rather than selling proprietary sensors or reconstructing thoughts. | Los Angeles, California |
 Axoft | Axoft Inc., clinical-stage developer of ultrasoft implantable neural interfaces and Fleuron materials. CEO/co-founder Paul Le Floch. Disclosed seed $8M and April 2026 Series A $55M total $63M across those rounds; unrelated to similarly named software companies. | Cambridge, Massachusetts, United States |
 Beacon Biosignals | AI-driven brain-health insights and FDA-cleared Waveband home EEG. | Boston, Massachusetts |
 Bitbrain | Bit&Brain Technologies S.L., University of Zaragoza spin-off developing EEG and human-monitoring hardware/software. Founded by Maria Lopez-Valdes and Javier Minguez. Offers Diadem, Hero, Versatile and Elevvo; New York office also listed. | Zaragoza, Spain |
 Blackrock Neurotech | Neurotechnology company formerly Blackrock Microsystems, developing Utah/NeuroPort recording systems and the MoveAgain BCI. Tether became majority stakeholder in April 2024; the $200M control transaction is distinct from ordinary financing. | Salt Lake City, Utah · Salt Lake City, Utah, United States |
 Boston Scientific | Boston Scientific Corporation is a global medical-technology manufacturer founded in 1979 and listed on the New York Stock Exchange as BSX. Headquartered in Marlborough, Massachusetts, it develops devices and therapies for cardiovascular, neurological, urological, digestive, respiratory and oncological diseases. Its neuroscience businesses include Vercise deep brain stimulation, WaveWriter spinal cord stimulation and other interventional pain and peripheral-nerve therapies. Device regulatory clearances and approvals are product- and indication-specific; its corporate pipeline is not universally approved. Its corporate venture investment activity is branded Boston Scientific Ventures and backs innovative medical solutions from research through commercialization worldwide. The company’s own site reports more than USD1 billion cumulatively invested in over 70 companies since 2012 and over 40 active holdings; this is deployment across a corporate portfolio, not a single externally raised venture fund. Boston Scientific frequently acquires former venture holdings. Direct issuer financing identifies the corporation as Enspire DBS Therapy’s USD2.5 million strategic investor, disclosed in January 2017; the exact investment closing date is unknown. The retained corporate Company identity and older management affiliations are preserved, while balance-sheet debt issuance is distinguished from venture investing and acquisition consideration. | Marlborough, Massachusetts, United States |
 BrainCo | Neurotechnology group founded by Han Bicheng, with Zhejiang Strong Brain Technology and US BrainCo Inc. operations. Offers EEG products and EMG/bionic prosthetics. Group legal ownership needs further mapping; R&D funding claims are not an equity-round ledger. | Hangzhou, China · Somerville, Massachusetts, United States |
 Brainomix | University of Oxford spinout developing AI-powered imaging biomarkers and clinical decision software for stroke, lung fibrosis, and life-sciences clinical development. | Oxford, United Kingdom |
 BrainRobotics | Prosthetics business operated under the BrainRobotics brand by BrainPortfolio Inc., per July 2026 terms. Develops bionic prostheses, including Kneuro knee; historical hand work uses EMG. Historical BrainCo relationship does not prove current ownership; do not copy BrainCo financing. | Austin, Texas, United States |
 CereGate | CereGate GmbH, private neurotechnology business encoding information through existing neuromodulation implants. Founder Balint Varkuti; current managing director/CEO Matthias Puls. Exact incorporation year remains unverified. | Munich, Germany |
 Cogitat | Imperial College London spinout building device-agnostic EEG decoding software that converts brainwaves into digital commands (motor imagery, attention, cognitive load) without per-user calibration. Products include CogiGame for thought-controlled VR stroke rehabilitation and CogiSense for real-time cognitive monitoring. Winner of the NeurIPS 2021 BEETL EEG transfer-learning competition. | London, United Kingdom · Royston, Hertfordshire, United Kingdom · Thessaloniki, Greece |
 Cognixion | Cognixion develops assistive communication technology that combines brain-computer interfaces, biological sensors and augmented reality. Its products aim to help people with complex speech and movement disabilities interact with digital systems and communicate. | Santa Barbara, California, United States |
 Compumedics | Compumedics Limited, public Australian medical-device company (ASX CMP), founded by David Burton. Supplies Neuroscan EEG, OrionMEG, sleep diagnostics and blood-flow systems. Listed in 2000; revenue and market capitalization are not financing rounds. | Abbotsford, Victoria, Australia |
 Conduit | Conduit is developing a non-invasive brain-computer interface that uses a headset and AI to complete typed sentences from a user's thoughts. The company conducts paid, in-person data collection and testing sessions at its San Francisco office. | San Francisco, California |
 CorTec | CorTec GmbH, private developer and contract manufacturer of implantable neurotechnology including investigational Brain Interchange recording/stimulation. Current CEO Frank Desiere; co-founder/CTO Martin Schuttler. Keep EIC grants separate from equity. | Freiburg, Germany |
 Cumulus Neuroscience | Clinical neuroscience company, formerly BrainWaveBank, developing NeuLogiq: an at-home dry-EEG headset, cognitive assessments, and AI-derived digital biomarkers for CNS trials. | Belfast, Northern Ireland · Dublin, Ireland |
 Dcode.AI | Dcode.AI is building the Large Brain Model (LBM), a universal EEG foundation model it says is trained on Emotiv's 15-year consumer/research EEG corpus (claimed 300,000+ hours, 150,000+ subjects, 156 countries). The product stack is Emotiv-FM: an on-device Mamba-2 U-Net (about 1-4M parameters) plus a cloud EEG-X transformer (~14M parameters), licensed as an embedded SDK, annual platform license, and usage-based API. Target users are device manufacturers, enterprise/pharma/defense platforms, developers, and researchers. Tan Le is listed as CEO and founder of both Emotiv and Dcode.AI; Geoff Mackellar as CTO and co-founder. Public scientific work cited on the site includes EEG2Rep, EEGM2, EEG-X, SAMBA, and SpellerSSL, published from Emotiv Research. The site solicits investor conversations and a deck; no announced financing round was found. | |
 Egra | BCI company training EEG foundation models and using involuntary biosignals as reward for AI alignment (reinforcement learning from biofeedback). Building a biosignal foundation model, capture hardware, and an alignment platform for frontier-lab post-training. | New York, New York |
 EMOTIV | Private EEG hardware/software company, maker of EPOC X, Insight, EPOC Flex and Cortex. Current company traces founding to 2011, distinct from earlier Emotiv Systems history. Conflicting CTO announcements and unverified inbound funding totals remain qualified. | San Francisco, California · Sydney, Australia · Hanoi, Vietnam · Ho Chi Minh City, Vietnam · San Francisco, California, United States |
 g.tec Medical Engineering | g.tec medical engineering GmbH, private developer of EEG/BCI hardware and software including g.USBamp, g.HIamp and recoveriX. Founded by Christoph Guger and Gunter Edlinger. Corporate financing totals undisclosed; institutional research grants are not automatically company capital. | Schiedlberg, Austria |
 Gestala | Gestala (Chengdu) Technology Co., Ltd., registered September 2025 and publicly launched January 2026. Developing ultrasound brain-computer interfaces. Founder/CEO Phoenix Peng. Official July financing headline/body disagree (RMB430M versus RMB420M); retain the discrepancy. | Chengdu, China · Shanghai, China |
 Hemispheric | Israeli NeuroAI company building Descartes, a six-billion-parameter frontier foundation model that translates non-invasive EEG and behavioral data into quantitative clinical insights. A patient wears a dry-electrode EEG headset for about 15 minutes while completing tablet or phone tasks. The company says Descartes was trained on more than 250,000 hours of multimodal data from over 100,000 participants collected through a global research network spanning Asia, Israel, and Boston. First applications target PTSD, mild traumatic brain injury, depression, anxiety, schizophrenia, and Alzheimer's. Co-founded by CEO Dr. Hagai Lalazar and CTO Gidi Littwin. Emerged from stealth in July 2026 with $52 million in disclosed early-stage funding. | Tel Aviv, Israel |
 IDUN Technologies | IDUN Technologies AG, ETH Zurich spin-off developing in-ear EEG sensing and the Guardian platform. Founded by Simon Bachmann and Severine Gisin (formerly Chardonnens). CHF12M total and shipment claims remain unverified. | Opfikon, Switzerland |
 INBRAIN Neuroelectronics | INBRAIN Neuroelectronics S.L., private clinical-stage developer of graphene-based bidirectional neural interfaces and neuromodulation. Investigational products. Carolina Aguilar is CEO/co-founder; founding accounts differ between 2019 and 2020. | Barcelona, Spain |
 Kandu | Kandu Inc., formed from the 2025 merger of Kandu Health and Neurolutions, combining stroke care and IpsiHand rehabilitation. Current CEO Leo Petrossian. April 2025 release announced first close of a $30M financing; amount actually received at first close is unspecified. | Van Nuys, California, United States |
 Kernel Neurotech | Private neurotechnology company founded by Bryan Johnson, developing noninvasive optical brain measurement, Flow and BrainAge/Cognition Trackers. Distinct from eatkernel.com and crypto KernelDAO. Ryan Field departed August 28, 2026; successor CEO is unverified. | Culver City, California, United States |
 Linus Health | Digital brain-health company using multimodal cognitive assessments, neuroscience, and AI for early detection and longitudinal monitoring of cognitive impairment and neurological disease. | Boston, Massachusetts |
 Lys | Non-invasive BCI research and product lab. Wearable consumer interface using fNIRS/neurofeedback so people can communicate with AI without surgery. Named after the land of Lys in Arthur C. Clarke's Against the Fall of Night. | San Francisco, California |
 MELTIN MMI | Current 株式会社メルティンMMI, incorporated August 8, 2024, corporate number 2010001247406. Robotics/body-augmentation business. Separate from closed 2013 predecessor; historical funding is not current-company financing. MELTz business transferred to FrontAct in June 2024. | Tokyo, Japan |
 MindMaze Therapeutics | MindMaze Therapeutics Holding SA, public successor listed on SIX as MMTX. Formed through the December 2025 Relief Therapeutics/NeuroX business combination following transfer of strategic MindMaze assets. Zach Henderson is current CEO; historical MindMaze funding is separate. | Geneva, Switzerland |
 MindPortal | | |
 Neurable | Private developer of noninvasive dry-EEG sensing and AI in everyday wearables, including MW75 Neuro headphones and a licensing platform. Company reported $65M total in December 2025; source round labels are retained. | Boston, Massachusetts · Boston, Massachusetts, United States |
 Neuralink | Private neurotechnology company developing the investigational N1 neural implant and R1 surgical robot. SEC principal business address is Fremont; Austin operations do not establish headquarters. Current CEO title remains qualified. | Fremont, California · Fremont, California, United States |
 Neuroelectrics | Neurotechnology company developing Enobio wireless EEG and Starstim systems that combine EEG monitoring with personalized non-invasive electrical brain stimulation. | Barcelona, Spain · Boston, Massachusetts |
 Neurolutions | Historical Neurolutions Inc., originating in Eric Leuthardt’s Washington University laboratory, developer of IpsiHand EEG-controlled stroke rehabilitation. Merged with Kandu Health in 2025 to form Kandu Inc.; now an endorsed business brand. Successor financing is not Neurolutions financing. | St. Louis, Missouri, United States |
 NeuroPace | Public medical-device company (Nasdaq NPCE), maker of the RNS System for drug-resistant focal epilepsy. Incorporated in 1997; some operating histories use 1999. Joel Becker became CEO in July 2023. | Mountain View, California, United States |
 NeuroSky | NeuroSky Inc., noninvasive EEG/biosensor component and device supplier, maker of MindWave. Founder Stanley Yang is chairman in March 2026 sources; historical CEO title should not be assumed current. Founding year is not primary-confirmed. | San Jose, California, United States |
 Neurotechnology | Neurotechnology UAB, private Lithuanian company developing biometrics and neural-interface products. BrainAccess is its EEG/BCI brand launched in 2019, not a separate startup. Company discloses sole ownership by Algimantas Malickas. | Vilnius, Lithuania |
 Next Sense | Neurotechnology company spun out of Alphabet's X developing dry-contact in-ear EEG earbuds and cloud analytics for sleep, seizure detection, focus, and closed-loop brain sensing. | Mountain View, California |
 nubrain | Foundation models for non-invasive neural decoding. Reconstructs objects/images and early thought-to-text from EEG, with a Human Mind API and headset on a waitlist. Founded 2025 by Priyanka Jain (CEO) and Ingo Marquardt (CTO). | San Francisco, California · Berlin, Germany · New York, New York |
 ONWARD Medical | Public medical-device company ONWARD Medical N.V. (Euronext ONWD), developing spinal-cord stimulation and ARC therapies. ARC-EX approvals differ from investigational ARC-IM and ARC-BCI. Lausanne is an office/scientific origin, not current sole HQ; unrelated to Onward fintech. | Eindhoven, Netherlands |
 OpenAI | OpenAI develops artificial general intelligence products including ChatGPT and the GPT model family. Khosla Ventures was the first venture firm to invest, writing a $50 million check around the 2019 OpenAI LP formation, and later raised a $405 million SPV around OpenAI's October 2024 financing. | San Francisco, California |
 OpenBCI | Open-source biosensing company founded by Conor Russomanno and Joel Murphy, offering EEG/EMG/ECG hardware including Cyton, Ultracortex and Galea. Rewards crowdfunding is separate from equity financing. | Brooklyn, New York, United States |
 Piramidal | Piramidal builds a foundation model for the brain trained on EEG, with a first clinical product in ICU / continuous EEG interpretation. The bet is a general brain model that transfers across people and devices. | New York, New York · San Francisco, California · London, United Kingdom |
 Precision Neuroscience | Private neural-interface company developing Layer 7 cortical-surface arrays. Its 2025 FDA clearance covers temporary use up to 30 days; a permanent paralysis-treatment BCI remains investigational. Company reported $430M cumulative capital in September 2026. | New York, New York · New York, United States |
 Rune Labs | Precision-neurology software company integrating electrophysiology, brain imaging, implanted-device, wearable, and clinical data for neurological care, biomarkers, and CNS therapy development. | San Francisco, California |
 Sabi | Sabi Inc. is a Palo Alto neurotechnology company developing a noninvasive brain-computer interface in a wearable cap. Its founders are CEO Rahul Chhabra and CTO Atmadeep Banerjee. The company combines custom neuroimaging sensors and ASICs with AI models trained on neural recordings, aiming to translate attempted speech and neural intent into computer input. Its current website presents beanie, cap and bucket-hat formats and invites prospective users to a waitlist. Its founder describes invite-only early access; general commercial availability and clinical efficacy are not established by those announcements. Claims about the largest neural dataset or most capable brain model are company claims rather than independently established research results. Banerjee’s published neuro-AI research includes fMRI-to-image reconstruction; that research does not itself validate the performance of Sabi’s wearable EEG product. The company publicly launched from stealth in April2026 and has a Bengaluru research and operations team. Primary founder communications name Khosla Ventures, Accel, Initialized Capital, Kevin Weil and Seattle Ascend as backers. Total financing amount, individual allocations and closing date remain undisclosed in the verified primary announcement. Sabi’s present materials describe a consumer computing interface; no FDA clearance or approval for a medical indication is established by the reviewed company sources. | Palo Alto, California, United States · Bengaluru, Karnataka, India |
 Science Corporation | Private neural-engineering company developing PRIMA retinal prostheses, biohybrid neural interfaces and related platforms. Founded by Max Hodak, Alan Mardinly and Emma Zhou. Company reported approximately $490M invested as of March 2026. | Alameda, California · Research Triangle Park, North Carolina · Paris, France · Alameda, California, United States |
 Subsense | Private developer of investigational nanoparticle-based non-surgical NanoBCI technology. Publicly launched February 2025; no longer stealth. CEO Tetiana Aleksandrova. Disclosed seed financing comprises $17M plus a $10M extension, totaling $27M. | Palo Alto, California, United States |
 Synchron | Private endovascular brain-computer interface company developing the investigational Stentrode. Founded by Thomas Oxley and Nicholas Opie; operations also in Melbourne and San Diego. | New York, New York · Melbourne, Australia · New York, United States |
 Wearable Sensing | Private EEG hardware company founded and led by Walid Soussou, supplying dry-electrode and hybrid EEG/fNIRS research systems. Exact legal suffix and founding year are unverified; no disclosed financing total established. | San Diego, California, United States |
| mBrainTrain | mBrainTrain LLC Belgrade, Serbian commercial mobile EEG supplier, maker of Smarting. CEO/co-founder Ivan Gligorijevic, CTO Bogdan Mijovic. Eleven-backed; investment and Serbian Innovation Fund grant amounts undisclosed. | Belgrade, Serbia |
| MELTIN MMI Predecessor | Closed historical 株式会社メルティンMMI, corporate number 7012401024371, founded July 19, 2013. Raised the 2018 Series B; do not attribute that round to the 2024 corporation with the same name. MELTz business transferred to FrontAct in June 2024. | Tokyo, Japan |
| Merge Labs (legacy duplicate) | Legacy duplicate of canonical MergeLabs at merge.io. Financing reconciled to canonical record; this row is retained as an archive, not another company to enrich. | |
| Neuracle Medical Technology | Neurotechnology business with current parent 博睿康技术（上海）股份有限公司 and Changzhou origins. Supplies commercial EEG/neuroscience products and develops NEO interfaces. NEO’s Shanghai medical-device registrant is a related, distinct entity. Founders Xu Honglai and Huang Xiaoshan. IPO fundraising target is not proceeds. | Shanghai, China |
| Saluda Medical | Public medical-device company (ASX SLD since December 2025), developer of Evoke closed-loop spinal-cord stimulation and EVA sensing/programming for pain. Mike Mathias is current CEO; this is spinal stimulation, not a brain implant. | Artarmon, New South Wales, Australia |
| Shanghai Active Technology | 上海主动科技有限公司, invasive BCI developer spun out of Lingang Laboratory, associated with the Tianshu 1024-channel system. Investor confirms Jia Jing CTO; legal details and CEO rely partly on secondary registry/reporting. Official domain and company portrait remain unverified. | Shanghai, China |
 &AI | &AI is an artificial-intelligence software company founded in2024 by Caleb Harris and Herbert (Herbie) Turner. It builds a collaborative workspace for patent litigators, including prior-art research, claim charts, invalidity and infringement analysis. Its tools help professionals review cited evidence and prepare patent work products. Y Combinator identifies the company as a Summer2024 participant based in San Francisco.
Its public leadership comprises CEO Caleb Harris and CTO Herbert Turner, accompanied by eight named external legal advisers. These advisers are not presented as employees or statutory directors. A complete engineering roster, exact legal incorporation details and appointment dates remain unpublished or unverified. The original &AI logo and genuine named company/investor portraits replace the previously generated nameplate. Existing organization ID AI is preserved.
The issuer's February6,2025 announcement confirms a USD6.5M seed financing. Existing institutional and Liz Wessel personal investment records are retained. A legacy Signal-derived personal round reports USD7M on the same date; its cash amount and relationship to the issuer-announced round require reconciliation and are not treated here as another verified USD7M raise. Two legacy First Round organization references also require exact identity and protected-dependency review before consolidation. No additional cash, employee identities or investor tickets are inferred. | San Francisco, United States |
 &Open | Mindfulness studio. | |
 &Open | Mindfulness studio. | |
 .lumen | .lumen (Dotlumen SRL) is a Romanian deep technology company founded in 2020 and based in Cluj-Napoca. It develops Pedestrian Autonomous Driving AI, combining computer vision, onboard environment understanding and directional haptic feedback. Its Glasses for the Blind use six cameras and run navigation locally to identify safe walking paths and guide users through vibrations on the forehead while preserving hearing. The company announced CE certification in May 2025 and is scaling manufacturing with Arrow Electronics, with a Japan pilot supported by Toyota Mobility Foundation in 2026. Its work includes sensory substitution and clinical usability research; it does not claim a neural implant or restoration of biological vision. The same pedestrian AI is being developed for autonomous urban delivery robots. The current site reports over 50 researchers, engineers and designers, but many team members are named only by first name. A €5 million investment closed in January 2025 led by Catalyst Romania, including EIC Fund, Tigrim and €1 million of crowdfunding facilitated by SeedBlink. EIT Urban Mobility announced a further investment in December 2025 with undisclosed amount. EU grants and consortium project budgets are tracked separately from equity financing. | Cluj-Napoca, Romania |
 011h | Construction technology company delivering residential buildings through industrialized design and building processes, engineered timber and coordinated manufacturing supply chains. It combines digital planning with low-carbon materials and standardized production to reduce construction waste, emissions and delivery uncertainty. | |
 012 Kudo | Enterprise Software company. | |
 01Health | 01Health operates in Healthcare. | |
 031 Modumetal | | |
 0pass | | |
 10% Happier | | |
 100 Thieves | 100 Thieves operates in Gaming. | |
 1000Memories | 1000Memories was a photo digitization and family-history service whose ShoeBox app helped people scan, organize and share old photographs; Ancestry acquired it in 2012. | |
 100ms | 100ms operates in Developer Tools. | |
 100Plus | Remote patient monitoring. | San Francisco, California, US |
 1047 games | | |
 1047 Games | Company operating in Gaming. | |
 10Ants | 10Ants is a property technology and business services company that brings underused commercial buildings back into use, initially in Thailand. Its platform connects owners of shophouses, warehouses and other idle premises with small and medium sized businesses seeking affordable space. It helps owners market and improve properties, and supports tenants with site selection, feasibility analysis, branding and business expansion. Its sustainability services include environmental assessments, energy efficiency advice and green upgrades, helping existing buildings serve businesses with a smaller environmental footprint. | |
 10Web | Provides an AI-assisted website building, hosting and management platform for WordPress sites and online businesses. | |
 10x Science | 10x Science operates in Biotech & Life Sciences. | |
 11x | 11x operates in Enterprise Software. | |
 1337 (Leet) | AI company. | |
 13th Lab | 13th Lab was a Stockholm computer-vision startup whose technology created real-time 3D models of physical environments for mobile and virtual-reality applications; Oculus acquired it in 2014. | |
 14.ai | AI company. | |
 15Five | 15Five is a performance management platform that helps businesses improve employee engagement, performance, and retention through continuous feedback, OKRs, performance reviews, engagement surveys, and more – now augmented by AI coaching tools like Kona. | 🇺🇸 · USA |
 1910 Genetics | Company operating in Biotech & Life Sciences. | |
 1club | Develops AI-native management software for gyms, fitness studios and sports clubs. Its platform combines membership management, scheduling, billing and payments, marketing, websites and member engagement, with conversational AI reporting and workflow automation. Its sports network helps people discover activities and book sessions with participating clubs. | |
 1KOMMA5° | 1KOMMA5° operates in Climate & Energy. | |
 1MRobotics | Company operating in Mobility & Transportation. | |
 1Password | Human-centric password and credentials platform for consumers and businesses. Founded 2005. Toronto. | Toronto, Canada |
 1stdibs | 1stdibs operates in E-Commerce & Marketplace. | |
 1Up | Company operating in AI. | |
 1up Health | Healthcare company. | https://www.wikidata.org/wiki/Q100, https://www.wikidata.org/wiki/Q771, http://www.wikidata.org/entity/Q30 |
 222 | 222 is an AI social-facilitation marketplace that matches people into curated in-person gatherings at local venues and events. | |